FDA NDC Directory · JSON-LD · Markdown

Octreotide Acetate

NDC 0641-6174 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076313
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsOCTREOTIDE ACETATE (50 ug/mL)
Marketing started20050404
Package count1

External sources

Source: openFDA. Public-domain (CC0).